Please assess the completion status of the following clinical trial:

Trial Title: Clarithromycin in Multiple Myeloma Induction Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Myeloma diagnosis according to IMWG criteria~* Treatment demanding disease~* High-dose melphalan with stem cell support scheduled as a part of the treatment~* Signed informed consent given prior to any study related activities~* Age \> 18 years~Exclusion Criteria:~* Allogeneic transplantation scheduled as a part of the treatment~* Myeloma treatment prior to entry in the study, except radiotherapy, bisphosphonates/denosumab or corticosteroids for symptom control~* Concurrent disease making clarithromycin treatment unsuitable~* Positive pregnancy test (only applicable for women with childbearing potential)~* Known or suspected hypersensitivity or intolerance to clarithromycin~* Prolonged QT corrected (QTc) interval ( \> 500 msec on screening ECG)~* Concurrent treatment with cabergoline, fluconazole, ketoconazole, pimozide, quetiapine, sirolimus, verapamil, tacrolimus, ergot alkaloid, simvastatin or other statins~* Uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrolment, uncontrolled angina or known cardiac amyloidosis~* Severe renal dysfunction (estimated creatinine clearance \<10 mL/min)~* Serious medical or psychiatric illness which, in the judgment of the investigator, would make the patient inappropriate for entry into the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Clarithromycin (Type: EXPERIMENTAL): Clarithromycin combined with VCD induction therapy
- Placebo (Type: PLACEBO_COMPARATOR): Placebo combined with VCD induction therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).